Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Work In Process (2016 - 2025)

Collegium Pharmaceutical has reported Work In Process over the past 10 years, most recently at $11.6 million for Q3 2025.

  • Quarterly results put Work In Process at $11.6 million for Q3 2025, down 33.12% from a year ago — trailing twelve months through Sep 2025 was $11.6 million (down 33.12% YoY), and the annual figure for FY2024 was $13.2 million, up 95.3%.
  • Work In Process for Q3 2025 was $11.6 million at Collegium Pharmaceutical, down from $12.1 million in the prior quarter.
  • Over the last five years, Work In Process for COLL hit a ceiling of $46.4 million in Q2 2022 and a floor of $802000.0 in Q1 2021.
  • Median Work In Process over the past 5 years was $11.6 million (2025), compared with a mean of $14.1 million.
  • Biggest five-year swings in Work In Process: surged 4252.49% in 2022 and later plummeted 83.92% in 2023.
  • Collegium Pharmaceutical's Work In Process stood at $1.0 million in 2021, then skyrocketed by 2350.05% to $24.7 million in 2022, then crashed by 72.68% to $6.7 million in 2023, then skyrocketed by 95.3% to $13.2 million in 2024, then fell by 11.65% to $11.6 million in 2025.
  • The last three reported values for Work In Process were $11.6 million (Q3 2025), $12.1 million (Q2 2025), and $11.6 million (Q1 2025) per Business Quant data.